Search…

Ed Bio: Shareholder Xiamen KeYing completes reduction of 1.00% stake.

15/05/2025

Eden Bioscience announced that shareholder Xiamen Keying Investment Partnership Enterprise has completed its reduction plan, reducing its holdings by 3,925,200 shares through block trades from April 23, 2025 to May 13, 2025, accounting for 1.00% of the total share capital. After the reduction, Xiamen Keying's shareholding percentage decreased to 4.06%.

Latest

3 m ago

Bain & Company stated that it has revised its sales forecast for the luxury goods industry in 2025 to a possible decrease of 2%-5%, compared to the previous expectation of growth of 0%-4%.

3 m ago

Biyin Lefen (002832.SZ) director Shen Jindong plans to reduce his holdings by no more than 4.913 million shares.

4 m ago

Etoro Group Ltd., a financial technology company that offers trading services for stocks, cryptocurrencies, ETFs, indices, currencies, commodities, etc., opened at $69.69 on its first day of trading on the US IPO. The IPO price previously announced was $52 per share.

4 m ago

Financial technology company Etoro Group Ltd. (ETOR), which provides trading services for stocks, cryptocurrencies, ETFs, indices, currencies, commodities, etc., opened at $69.69 on its first day of IPO in the US, with the IPO price previously set at $52 per share.

6 m ago

The actual controller of Harmony and Tait (002402.SZ), Liu Jianwei, plans to reduce his shareholding by no more than 2%.

See all latest